Stratec SE
XETRA:SBS
Operating Margin
Stratec SE
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| DE |
|
Stratec SE
XETRA:SBS
|
303.9m EUR |
8%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
224.3B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
180.8B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
150.1B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.7B USD |
19%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.1B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.7B EUR |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.2B USD |
28%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.2B USD |
29%
|
Stratec SE
Glance View
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Stratec SE's most recent financial statements, the company has Operating Margin of 7.6%.
You don't have any saved screeners yet